3 Firms Sculpt PerkinElmer's $5.25B Buy Of Life Sciences Co.
Scientific instrument maker PerkinElmer will pay about $5.25 billion to pick up BioLegend, which provides reagents and antibodies for use in areas including immunology and neuroscience, in a deal shaped by three...To view the full article, register now.
Already a subscriber? Click here to view full article